1. Home
  2. KNSA vs SIMO Comparison

KNSA vs SIMO Comparison

Compare KNSA & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • SIMO
  • Stock Information
  • Founded
  • KNSA 2015
  • SIMO 1995
  • Country
  • KNSA United Kingdom
  • SIMO Cayman Islands
  • Employees
  • KNSA N/A
  • SIMO N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • SIMO Semiconductors
  • Sector
  • KNSA Health Care
  • SIMO Technology
  • Exchange
  • KNSA Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • KNSA 2.1B
  • SIMO 2.4B
  • IPO Year
  • KNSA 2018
  • SIMO 2005
  • Fundamental
  • Price
  • KNSA $27.12
  • SIMO $73.20
  • Analyst Decision
  • KNSA Strong Buy
  • SIMO Strong Buy
  • Analyst Count
  • KNSA 6
  • SIMO 8
  • Target Price
  • KNSA $39.33
  • SIMO $80.00
  • AVG Volume (30 Days)
  • KNSA 980.0K
  • SIMO 299.2K
  • Earning Date
  • KNSA 07-29-2025
  • SIMO 07-30-2025
  • Dividend Yield
  • KNSA N/A
  • SIMO 2.73%
  • EPS Growth
  • KNSA N/A
  • SIMO 59.19
  • EPS
  • KNSA N/A
  • SIMO 2.80
  • Revenue
  • KNSA $481,166,000.00
  • SIMO $780,733,000.00
  • Revenue This Year
  • KNSA $37.21
  • SIMO $2.27
  • Revenue Next Year
  • KNSA $5.32
  • SIMO $13.72
  • P/E Ratio
  • KNSA N/A
  • SIMO $25.70
  • Revenue Growth
  • KNSA 59.45
  • SIMO 10.84
  • 52 Week Low
  • KNSA $17.82
  • SIMO $37.21
  • 52 Week High
  • KNSA $30.69
  • SIMO $76.77
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 43.14
  • SIMO 55.48
  • Support Level
  • KNSA $28.19
  • SIMO $71.16
  • Resistance Level
  • KNSA $29.58
  • SIMO $75.21
  • Average True Range (ATR)
  • KNSA 0.93
  • SIMO 2.19
  • MACD
  • KNSA -0.13
  • SIMO -0.52
  • Stochastic Oscillator
  • KNSA 3.15
  • SIMO 57.04

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: